These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32811803)

  • 1. A Review of Clinical and Preclinical Studies on Therapeutic Strategies Using Interleukin-12 in Cancer Therapy and the Protective Role of Interleukin-12 in Hematological Recovery in Chemoradiotherapy.
    Li P; Zhang H; Ji L; Wang Z
    Med Sci Monit; 2020 Aug; 26():e923855. PubMed ID: 32811803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-12: biological properties and clinical application.
    Del Vecchio M; Bajetta E; Canova S; Lotze MT; Wesa A; Parmiani G; Anichini A
    Clin Cancer Res; 2007 Aug; 13(16):4677-85. PubMed ID: 17699845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-12: potential role in cancer therapy.
    Brunda MJ; Gately MK
    Important Adv Oncol; 1995; ():3-18. PubMed ID: 7672811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12 facilitates both the recovery of endogenous hematopoiesis and the engraftment of stem cells after ionizing radiation.
    Chen T; Burke KA; Zhan Y; Wang X; Shibata D; Zhao Y
    Exp Hematol; 2007 Feb; 35(2):203-13. PubMed ID: 17258069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-3 in hematology and oncology: current state of knowledge and future directions.
    Mangi MH; Newland AC
    Cytokines Cell Mol Ther; 1999 Jun; 5(2):87-95. PubMed ID: 10515681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo therapeutic effects of interleukin-12 against highly metastatic residual lymphoma.
    Verbik DJ; Stinson WW; Brunda MJ; Kessinger A; Joshi SS
    Clin Exp Metastasis; 1996 May; 14(3):219-29. PubMed ID: 8674276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.
    Laughlin MJ; Kirkpatrick G; Sabiston N; Peters W; Kurtzberg J
    Ann Hematol; 1993 Dec; 67(6):267-76. PubMed ID: 7506580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 1 trials in cancer patients: a review of the toxicity, antitumor and hematopoietic effects.
    Veltri S; Smith JW
    Stem Cells; 1996 Mar; 14(2):164-76. PubMed ID: 8991536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1β as emerging therapeutic target in hematological malignancies and potentially in their complications.
    Arranz L; Arriero MDM; Villatoro A
    Blood Rev; 2017 Sep; 31(5):306-317. PubMed ID: 28495184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of interleukin 11 on normal and pathological thrombopoiesis.
    Teramura M; Kobayashi S; Yoshinaga K; Iwabe K; Mizoguchi H
    Cancer Chemother Pharmacol; 1996; 38 Suppl():S99-102. PubMed ID: 8765427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effects of interleukin-12 in pre-clinical and early clinical studies (Review).
    Golab J; Zagozdzon R
    Int J Mol Med; 1999 May; 3(5):537-44. PubMed ID: 10202188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer properties of the IL-12 family--focus on colorectal cancer.
    Engel MA; Neurath MF
    Curr Med Chem; 2010; 17(29):3303-8. PubMed ID: 20712574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-12 enhances peripheral hematopoiesis in vivo.
    Jackson JD; Yan Y; Brunda MJ; Kelsey LS; Talmadge JE
    Blood; 1995 May; 85(9):2371-6. PubMed ID: 7727771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-CSF prevents the suppression of bone marrow hematopoiesis induced by IL-12 and augments its antitumor activity in a melanoma model in mice.
    Gołab J; Stokłosa T; Zagozdzon R; Kaca A; Giermasz A; Pojda Z; Machaj E; Dabrowska A; Feleszko W; Lasek W; Iwan-Osiecka A; Jakóbisiak M
    Ann Oncol; 1998 Jan; 9(1):63-9. PubMed ID: 9541685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 6 perfusion stimulates reconstitution of the immune and hematopoietic systems after 5-fluorouracil treatment.
    Takatsuki F; Okano A; Suzuki C; Miyasaka Y; Hirano T; Kishimoto T; Ejima D; Akiyama Y
    Cancer Res; 1990 May; 50(10):2885-90. PubMed ID: 2334892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 1-induced sequential myelorestoration: dynamic relation between granulopoiesis and progenitor cell recovery in myelosuppressed mice.
    Ido M; Harada M; Furuichi H; Matsuoka N; Nakano K; Sohmura Y
    Exp Hematol; 1992 Feb; 20(2):161-6. PubMed ID: 1371964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bortezomib and IL-12 produce synergetic anti-multiple myeloma effects with reduced toxicity to natural killer cells.
    Wang X; Feng X; Wang J; Shao N; Ji C; Ma D; Henter JI; Fadeel B; Zheng C
    Anticancer Drugs; 2014 Mar; 25(3):282-8. PubMed ID: 24300915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I study of interleukin 12 with trastuzumab in patients with human epidermal growth factor receptor-2-overexpressing malignancies: analysis of sustained interferon gamma production in a subset of patients.
    Parihar R; Nadella P; Lewis A; Jensen R; De Hoff C; Dierksheide JE; VanBuskirk AM; Magro CM; Young DC; Shapiro CL; Carson WE
    Clin Cancer Res; 2004 Aug; 10(15):5027-37. PubMed ID: 15297404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of interleukin 12 with pulse interleukin 2 and the rapid and complete eradication of murine renal carcinoma.
    Wigginton JM; Komschlies KL; Back TC; Franco JL; Brunda MJ; Wiltrout RH
    J Natl Cancer Inst; 1996 Jan; 88(1):38-43. PubMed ID: 8847724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-gamma and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy.
    Wigginton JM; Gruys E; Geiselhart L; Subleski J; Komschlies KL; Park JW; Wiltrout TA; Nagashima K; Back TC; Wiltrout RH
    J Clin Invest; 2001 Jul; 108(1):51-62. PubMed ID: 11435457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.